
12.90 Delayed Data As of May 16 | ![]() Today’s Change | 6.25 Today|||52-Week Range 21.17 | -26.24% Year-to-Date |
X4 Pharmaceuticals (XFOR) Reports Q1 Loss, Misses Revenue Estimates May 12 / Zacks.com - Paid Partner Content | Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q1 Loss, Tops Revenue Estimates May 10 / Zacks.com - Paid Partner Content |
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates May 11 / Zacks.com - Paid Partner Content | Pliant Therapeutics, Inc. (PLRX) Reports Q1 Loss, Lags Revenue Estimates May 09 / Zacks.com - Paid Partner Content |
Previous close | 11.83 |
Today’s open | 11.67 |
Day’s range | 11.63 - 13.09 |
Volume | 399,417 |
Average volume (3 months) | 366,762 |
Market cap | $472.0M |
Earnings growth (last year) | +60.02% |
Earnings growth (this year) | +39.30% |
Earnings growth (next 5 years) | +11.78% |
Revenue growth (last year) | -45.65% |
P/E ratio | -- |
Price/Sales | 55.64 |
Price/Book | 1.55 |
Today’s change | Today’s % change | |
---|---|---|
BCYCBicycle Therapeutics... | 0.00 | 0.00% |
GERNGeron Corp | 0.00 | 0.00% |
SIGASIGA Technologies In... | -0.10 | -1.34% |
ANIPANI Pharmaceuticals ... | 0.00 | 0.00% |
Next reporting date | August 11, 2022 |
EPS forecast (this quarter) | -$0.48 |
Annual revenue (last year) | $9.7M |
Annual profit (last year) | -$62.0M |
Net profit margin | -637.19% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |